← Browse by Condition
Medical Condition

overweight and obesity

Total Trials
10
Recruiting Now
10
Trial Phases
Various

Obesity research has been transformed by the GLP-1 receptor agonist class (semaglutide, tirzepatide), which achieves 15–22% body weight reduction — approaching surgical outcomes — and reduces cardiovascular events in overweight adults. The pipeline now includes amylin analogs, glucose-dependent insulinotropic polypeptide (GIP) agonists, and oral small molecules targeting appetite regulation.

Active trials investigate next-generation GLP-1 combinations, bimagrumab (anti-ActRII for muscle-sparing weight loss), retatrutide, cagrilintide combinations, and gut microbiome modulators. Trials also study weight regain prevention after GLP-1 discontinuation — an emerging clinical challenge.

Obesity trials typically require a BMI ≥30 or ≥27 with weight-related comorbidities; prior bariatric surgery often excludes participants.

Frequently Asked Questions — overweight and obesity Clinical Trials

How many clinical trials are currently recruiting for overweight and obesity?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for overweight and obesity, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for overweight and obesity?
overweight and obesity research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a overweight and obesity clinical trial?
Eligibility criteria for overweight and obesity trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
University of Hawaii 2 trials
Drexel University 1 trial
San Diego State University 1 trial
Federal University of Minas Gerais 1 trial
Ulla Kampmann Opstrup 1 trial

Recruiting Clinical Trials

NCT06147973
Recruiting

An Acceptance-Based Healthy Lifestyle Intervention for Diverse Adolescents

Enrollment
148 pts
Location
United States
Sponsor
Drexel University
View Trial →
NCT05726942
Recruiting

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

Enrollment
30 pts
Location
United States
Sponsor
San Diego State University
View Trial →
NCT03574103
Recruiting

Chronic Effect of Fasting

Enrollment
45 pts
Location
Brazil
Sponsor
Federal University of Minas Ge...
View Trial →
NCT05798494
Recruiting

PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus

Enrollment
140 pts
Location
Denmark
Sponsor
Ulla Kampmann Opstrup
View Trial →
NCT05796141
Recruiting

Becoming United in Lifestyle Decisions

Enrollment
736 pts
Location
United States
Sponsor
University of Connecticut
View Trial →
NCT05866107
Recruiting

App and Body Fat Scale in the Management of Overweight Patients

Enrollment
204 pts
Location
China
Sponsor
Capital Medical University
View Trial →
NCT06526650
Recruiting

'Ai Pono Cooking Demonstrations

Enrollment
1,780 pts
Location
United States
Sponsor
University of Hawaii
View Trial →
NCT06526273
Recruiting

PILI 'Āina Household

Enrollment
210 pts
Location
United States
Sponsor
University of Hawaii
View Trial →
NCT03561766
Recruiting

Birth Cohort Study of China Medical University

Enrollment
1,000 pts
Location
China
Sponsor
Shengjing Hospital
View Trial →
NCT04583514
Recruiting

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

Enrollment
58 pts
Location
United States
Sponsor
Pennington Biomedical Research...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology